Table 2.
Late atrial arrhythmia
| Characteristics | No late AA n = 251 |
With late AA n = 42 |
Univariable HR(95%CI) |
p-value | Multivariable HR(95%CI) |
p-value |
|---|---|---|---|---|---|---|
| Age(year) | 56±14 | 61±11 | 1.04 (1.01,1.07) | 0.015 | 1.03 (0.97,1.09) | 0.364 |
| Male gender | 140 (55.8) | 28 (66.7) | 1.59 (0.83,3.02) | 0.159 | 0.89 (0.27,2.93) | 0.852 |
| BMI(kg/m2) | 25.3±5.6 | 26.7±5.2 | 1.05 (0.99,1.11) | 0.103 | 1.00 (0.90,1.10) | 0.955 |
| Pulmonary pathology | ||||||
| Group A; obstructive | 66 (26.3) | 11 (26.2) | 1.00 (Reference) | - | 1.00 (Reference) | - |
| Group B; vascular | 3 (1.2) | 3 (7.1) | 4.21 (1.16,15.26) | 0.028 | 80.83 (4.07,1604.32) | 0.004 |
| Group C; immunologic | 20 (8.0) | 1 (2.4) | 0.33 (0.04,2.57) | 0.291 | - | - |
| Group D; restrictive | 162 (64.5) | 27 (64.3) | 1.32 (0.65,2.67) | 0.438 | - | - |
| Preoperative O2 support(lpm) | 4 (3–6) | 2 (2–5) | 0.97 (0.90,1.04) | 0.369 | - | - |
| Ventilator/ECMO | 7 (2.8) | 0 (0) | 0.05 (0.01,>100) | 0.586 | - | - |
| History of CAD | 99 (46.5) | 22 (57.9) | 1.54 (0.81,2.95) | 0.188 | 3.89 (1.03,14.68) | 0.045 |
| History of hypertension | 131 (52.2) | 27 (64.3) | 1.63 (0.87,3.06) | 0.131 | 1.40 (0.42,4.65) | 0.586 |
| History of diabetes mellitus | 71 (28.3) | 15 (35.7) | 1.57 (0.83,2.95) | 0.165 | 2.41 (0.73,7.96) | 0.149 |
| History of dyslipidemia | 104 (41.4) | 19 (45.2) | 1.30 (0.71,2.39) | 0.404 | - | - |
| History of smoking | 103 (41.0) | 18 (42.9) | 1.04 (0.57,1.93) | 0.891 | - | - |
| History of stroke | 5 (2.0) | 0 (0) | 0.05 (0.01,>100) | 0.543 | - | - |
| CHADS2 score | 1 (0–1) | 1 (1–2) | 1.08 (0.59,1.99) | 0.808 | - | - |
| Serum creatinine (mg/dl) | 0.8±0.2 | 0.8±0.3 | 2.11 (0.67,6.70) | 0.204 | 0.78 (0.12,5.10) | 0.799 |
| Cardiovascular medications | ||||||
| Statins | 96 (38.2) | 11 (26.2) | 0.65 (0.32,1.28) | 0.212 | 0.17 (0.05,0.65) | 0.009 |
| Aspirin | 61 (24.3) | 9 (21.4) | 0.86 (0.41,1.81) | 0.699 | - | - |
| Beta blockers | 41 (16.3) | 12 (28.6) | 2.04 (1.04,3.99) | 0.037 | 1.06 (0.28,4.01) | 0.933 |
| ACEI | 33 (13.1) | 6 (14.3) | 1.26 (0.53,2.98) | 0.606 | - | - |
| ARB | 25 (10.0) | 3 (7.1) | 0.62 (0.19,2.00) | 0.423 | - | - |
| Calcium channel blockers | 40 (15.9) | 9 (21.4) | 1.50 (0.72,3.14) | 0.280 | - | - |
| Diuretics | 72 (28.7) | 14 (33.3) | 1.44 (0.75,2.73) | 0.271 | - | - |
| Echocardiographic data | ||||||
| LVEF (%) | 60±6 | 60±4 | 1.01 (0.95,1.06) | 0.851 | - | - |
| LVEDD (cm) | 4.2±0.6 | 4.3±0.6 | 1.25 (0.71,2.21) | 0.447 | - | - |
| IVSD (cm) | 1.00±0.83 | 0.89±0.41 | 0.73 (0.33,1.62) | 0.443 | - | - |
| LAV (cm3) | 40±19 | 44±18 | 1.01 (0.99,1.04) | 0.176 | 0.99 (0.96,1.02) | 0.543 |
| LAA (cm2) | 16±9 | 17±8 | 1.01 (0.98,1.05) | 0.360 | - | - |
| Right heart catheterization data | ||||||
| mPAP (kPa) | 3.47±1.20 (26±9 mmHg) | 3.60±1.60 (27±12 mmHg) | 1.01 (0.98,1.04) | 0.508 | - | - |
| Pulmonary hypertension | 89 (39.2) | 17 (44.7) | 1.18 (0.62,2.23) | 0.620 | - | - |
| PCWP (kPa) | 1.33±0.53 (10±4 mmHg) | 1.33±0.80 (10±6 mmHg) | 1.01 (0.94,1.08) | 0.874 | - | - |
| Double lung transplant | 157 (62.8) | 26 (61.9) | 0.98 (0.53,1.84) | 0.959 | - | - |
| Lung allocation score | 37.8 (33.8–45.0) | 38.2 (33.9–43.6) | 1.00 (0.98,1.02) | 0.795 | - | - |
| Ischemic time (minute) | 204±67 | 213±63 | 1.00 (1.00,1.01) | 0.361 | - | - |
| Peak troponin (mg/dl) | 7.0 (3.7–12.5) | 8.0 (4.1–17.8) | 1.00 (0.99,1.01) | 0.728 | - | - |
| Vasopressor use | 212 (84.5) | 35 (83.3) | 1.26 (0.56,2.87) | 0.575 | - | - |
| Postoperative AA | 48 (19.1) | 25 (59.5) | 6.08 (3.25,11.38) | <0.001 | 13.52 (3.90,46.93) | <0.001 |